Services
- Acne Treatment
- Psoriasis Treatment
- Eczema – Dermatitis
- Rosacea Treatment
- Hair and Nail Problems
- Skin Pigmentation
- Wart Removal
- Skin Check / Mole Map
- Melanoma
- Basal Cell Skin Cancer
- Squamous Cell Skin Cancer
- Non-surgical Skin Cancer Treatment
- Surgical Skin Cancer Treatment
- Anti Aging Treatments
- Patch Test for Allergy
Main Clinic
Wellington Dermatology Ltd
8 Upland Road, Kelburn, Wellington
The practice is at the top of the cable car from Lambton Quay (across the road)
Phone: 04 475 8664
Fax: 04 475 9699
Email:
Other Clinics
High Street Health Hub
577 High Street, Lower Hutt
Phone: 04 555 4450
Waikanae Specialists Centre
Marae Lane, Waikanae
Phone: 04 293 6644
COVID-19
/in Uncategorized /by clairePlease see our dedicated page here regarding Covid-19 and what the lockdown etc means for the clinic appointments.
Covid-19 Info
Potential fire hazard from skin products containing paraffin
/in Risks /by clairePotential fire hazard from skin products containing liquid paraffin and/or white soft paraffin. The skin products themselves are not flammable, it is the clothing, bedding or bandages covered in these skin products containing paraffin that are at risk of catching fire.
The risk does appear to be associated with white soft paraffin and/or liquid paraffin. Read more
Reported risk of some blood pressure medications and non-melanoma skin cancer
/in Risks /by Bruce TaylorTwo recent case studies in a Danish population have found an increased risk of non-melanoma skin cancer associated with use of Hydrochlorothiazide. This risk increases with cumulative dose. The increased risk is associated with non-melanoma skin cancer – basal cell carcinoma, squamous cell carcinoma and squamous cell carcinoma of the lip.
The exact mechanism is unknown, but Hydrochlorothiazide is known to sometimes cause photosensitising effects of the skin and make it more sensitive to ultraviolet light.
The same studies have found no significant risk with other blood pressure medicines.
Read more
Funding for Secukinumab (for psoriasis) and Omalizumab (for hives)
/in Treatments /by clairePharmac has announced funding for both Secukinumab (for severe psoriasis) and Omalizumab (for chronic hives) as of October 2018. These can be prescribed by a Dermatologist only. Read more